SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
Price:
29.61
CNY
2.71%
Market Closed
Market Cap:
¥2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
|
CN |
|
S
|
Shandong Link Science and Technology Co Ltd
SZSE:001207
|
CN |
Balance Sheet
Balance Sheet Decomposition
SICHUAN HZ-YEG MEDICAL Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd
Balance Sheet Decomposition is not available for
SICHUAN HZ-YEG MEDICAL Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd
Balance Sheet
SICHUAN HZ-YEG MEDICAL Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
23
|
54
|
68
|
95
|
135
|
357
|
191
|
334
|
|
| Cash |
0
|
0
|
0
|
0
|
135
|
357
|
191
|
235
|
|
| Cash Equivalents |
23
|
54
|
68
|
94
|
0
|
0
|
0
|
99
|
|
| Short-Term Investments |
0
|
1
|
0
|
0
|
0
|
7
|
4
|
6
|
|
| Total Receivables |
21
|
54
|
54
|
65
|
87
|
165
|
265
|
341
|
|
| Accounts Receivables |
14
|
21
|
30
|
27
|
28
|
69
|
123
|
185
|
|
| Other Receivables |
7
|
34
|
24
|
38
|
59
|
96
|
142
|
156
|
|
| Inventory |
169
|
223
|
292
|
338
|
468
|
447
|
561
|
517
|
|
| Other Current Assets |
99
|
133
|
129
|
112
|
142
|
288
|
355
|
189
|
|
| Total Current Assets |
312
|
465
|
543
|
609
|
832
|
1 264
|
1 376
|
1 386
|
|
| PP&E Net |
77
|
108
|
138
|
163
|
175
|
165
|
158
|
162
|
|
| PP&E Gross |
77
|
108
|
138
|
163
|
175
|
165
|
158
|
162
|
|
| Accumulated Depreciation |
6
|
8
|
15
|
23
|
38
|
53
|
68
|
73
|
|
| Intangible Assets |
33
|
32
|
31
|
39
|
42
|
60
|
70
|
68
|
|
| Goodwill |
0
|
0
|
3
|
3
|
3
|
16
|
16
|
17
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
48
|
2
|
1
|
|
| Long-Term Investments |
1
|
16
|
16
|
18
|
119
|
25
|
29
|
45
|
|
| Other Long-Term Assets |
4
|
14
|
13
|
7
|
17
|
13
|
36
|
38
|
|
| Other Assets |
0
|
0
|
3
|
3
|
3
|
16
|
16
|
17
|
|
| Total Assets |
426
N/A
|
634
+49%
|
744
+17%
|
839
+13%
|
1 187
+41%
|
1 592
+34%
|
1 687
+6%
|
1 717
+2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
45
|
78
|
88
|
118
|
129
|
371
|
360
|
333
|
|
| Accrued Liabilities |
11
|
11
|
8
|
7
|
14
|
30
|
29
|
32
|
|
| Short-Term Debt |
47
|
103
|
119
|
130
|
180
|
237
|
321
|
372
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
5
|
4
|
7
|
|
| Other Current Liabilities |
19
|
18
|
23
|
43
|
49
|
110
|
88
|
94
|
|
| Total Current Liabilities |
122
|
209
|
238
|
298
|
378
|
753
|
801
|
838
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
6
|
3
|
12
|
10
|
|
| Deferred Income Tax |
11
|
10
|
10
|
10
|
9
|
10
|
13
|
13
|
|
| Minority Interest |
0
|
2
|
11
|
7
|
14
|
6
|
2
|
1
|
|
| Other Liabilities |
2
|
2
|
8
|
6
|
6
|
6
|
5
|
5
|
|
| Total Liabilities |
134
N/A
|
223
+66%
|
268
+20%
|
321
+20%
|
414
+29%
|
778
+88%
|
833
+7%
|
867
+4%
|
|
| Equity | |||||||||
| Common Stock |
65
|
72
|
72
|
72
|
96
|
96
|
96
|
96
|
|
| Retained Earnings |
51
|
107
|
172
|
215
|
202
|
244
|
285
|
280
|
|
| Additional Paid In Capital |
176
|
232
|
232
|
231
|
476
|
476
|
474
|
474
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
292
N/A
|
411
+41%
|
476
+16%
|
518
+9%
|
774
+49%
|
814
+5%
|
854
+5%
|
850
-1%
|
|
| Total Liabilities & Equity |
426
N/A
|
634
+49%
|
744
+17%
|
839
+13%
|
1 187
+41%
|
1 592
+34%
|
1 687
+6%
|
1 717
+2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
65
|
72
|
72
|
72
|
96
|
96
|
96
|
96
|
|
Switch to:
Switch to:
See Also
Discover More
